ArticleLeukemia2026

The FGFR1 N546K mutation confers resistance to pemigatinib in MLN-ZMYM2::FGFR1.

Khalid Shoumariyeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.